Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.75 USD | +3.65% | -5.10% | -27.52% |
04-02 | EyePoint Pharmaceuticals, Inc. Expands Scientific Advisory Board | CI |
03-18 | EyePoint Pharmaceuticals, Inc.(NasdaqGM:EYPT) added to S&P Pharmaceuticals Select Industry Index | CI |
Business Summary
Number of employees: 121
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
License and Collaboration Agreements
66.9
%
| 0 | 0.9 % | 31 | 66.9 % | +8,407.46% |
Ophthalmic Products
30.9
%
| 40 | 96.4 % | 14 | 30.9 % | -64.34% |
Royalty
2.1
%
| 1 | 2.7 % | 1 | 2.1 % | -13.02% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
98.4
%
| 40 | 97.8 % | 45 | 98.4 % | +11.83% |
China
1.4
%
| 1 | 2.0 % | 1 | 1.4 % | -21.26% |
United Kingdom
0.2
%
| 0 | 0.2 % | 0 | 0.2 % | 0.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 26/09/16 |
George Elston
DFI | Director of Finance/CFO | 59 | 13/11/19 |
Said Saim
CTO | Chief Tech/Sci/R&D Officer | 66 | 09/06/19 |
Jennifer Leonard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Nancy Lurker
BRD | Director/Board Member | 66 | 14/09/16 |
General Counsel | - | 06/03/22 | |
Michael Pine
PRN | Corporate Officer/Principal | - | 06/01/22 |
Scott Jones
PRN | Corporate Officer/Principal | 57 | 09/06/19 |
Ron I. Honig
LAW | General Counsel | - | 26/11/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 26/09/16 |
Wendy DiCicco
BRD | Director/Board Member | 56 | 14/07/19 |
David Guyer
BRD | Director/Board Member | 64 | 24/01/19 |
Anthony Adamis
BRD | Director/Board Member | 65 | 22/06/22 |
Nancy Lurker
BRD | Director/Board Member | 66 | 14/09/16 |
Chairman | 75 | 26/06/18 | |
John Landis
BRD | Director/Board Member | 71 | 24/10/18 |
Karen Zaderej
BRD | Director/Board Member | 62 | 10/07/22 |
Stuart Duty
BRD | Director/Board Member | 59 | 15/10/23 |
Ye Liu
BRD | Director/Board Member | 53 | 31/12/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,830,792 | 48,731,637 ( 97.79 %) | 0 | 97.79 % |
Company contact information
EyePoint Pharmaceuticals, Inc.
480 Pleasant Street Suite A-210
02472, Watertown
+617 926 5000
http://www.eyepointpharma.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.52% | 872M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- EYPT Stock
- Company EyePoint Pharmaceuticals, Inc.